Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$3.0 million.

  • Medifast's Change in Inventory fell 22798.8% to -$3.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$22.2 million, marking a year-over-year decrease of 8235.83%. This contributed to the annual value of -$22.2 million for FY2025, which is 8235.83% down from last year.
  • According to the latest figures from Q4 2025, Medifast's Change in Inventory is -$3.0 million, which was down 22798.8% from -$7.0 million recorded in Q3 2025.
  • Over the past 5 years, Medifast's Change in Inventory peaked at $50.4 million during Q4 2021, and registered a low of -$32.0 million during Q2 2022.
  • For the 5-year period, Medifast's Change in Inventory averaged around -$1.7 million, with its median value being -$5.2 million (2023).
  • Its Change in Inventory has fluctuated over the past 5 years, first skyrocketed by 109572.07% in 2021, then plummeted by 152195.12% in 2025.
  • Quarter analysis of 5 years shows Medifast's Change in Inventory stood at $50.4 million in 2021, then plummeted by 152.4% to -$26.4 million in 2022, then surged by 86.24% to -$3.6 million in 2023, then soared by 163.97% to $2.3 million in 2024, then tumbled by 227.99% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q4 2025, -$7.0 million for Q3 2025, and -$9.2 million during Q2 2025.